Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
July 24, 1954


JAMA. 1954;155(13):1179-1180. doi:10.1001/jama.1954.03690310057017

Therapy of Leukemia.  —At the meeting of the Society of Physicians in Vienna, April 23, 1954, Dr. H. Fleishhacker discussed various new drugs used in leukemia and his studies on the properties of the spinal fluid. Healthy persons showed the same response to the passage of short waves through the diencephalon or to electroshock as patients with leukemia did, except that the total leukocyte counts in the leukemic patients were much higher. Intramuscular or intraspinal administration of 10 cc. of spinal fluid from a healthy donor or a patient with leukemia into persons with normal blood usually resulted in a great increase in the spinal fluid leukocyte count in the recipients; the spinal fluid, therefore, must contain an active substance, which is present in a more effective or more concentrated form in the patients with leukemia. The satisfactory results obtained with injections of spinal fluid in patients with panmyelopathies and

First Page Preview View Large
First page PDF preview
First page PDF preview